P

Inventor

HELDMAN ELIAHU

IL13 patents
⚠️ This page may combine multiple inventors who share the name “HELDMAN ELIAHU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV BEN GURION

3 patents
US7887833B2Feb 15, 2011

Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting

UNIV BEN GURION4 citations57
US7939562B2May 10, 2011

Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof

UNIV BEN GURION4 citations56
US8377469B2Feb 19, 2013

Nano- and mesosized particles comprising an inorganic core, process and applications thereof

UNIV BEN GURION1 citations46

ISRAEL STATE

2 patents
US4855290AAug 8, 1989

Derivatives of quinuclidine

ISRAEL STATE67 citations94
US5106831AApr 21, 1992

Pharmaceutical composition comprising a spiro oxathiolon/quinuclidine and method of treating senile dementia

ISRAEL STATE6 citations61

HELDMAN ELIAHU

2 patents
US8273731B2Sep 25, 2012

Compositions comprising nicotinic agonists and methods of using same

HELDMAN ELIAHU24 citations90
US8921356B2Dec 30, 2014

Compositions comprising nicotinic agonists and methods of using same

HELDMAN ELIAHU9 citations81

NEURODERM LTD

1 patent
US6746688B1Jun 8, 2004

Apparatus for the transdermal treatment of Parkinson's disease

NEURODERM LTD47 citations90

(unassigned)

1 patent
US6166081ADec 26, 2000

Methods and apparatus for treatment of Parkinson's disease

17 citations80

BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

1 patent
US10842747B2Nov 24, 2020

Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery

BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY2 citations71

LINDER CHARLES

1 patent
US9642803B2May 9, 2017

Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery

LINDER CHARLES4 citations71

LAUREN SCIENCES LLC

1 patent
US11304964B2Apr 19, 2022

Bolaamphiphilic compounds, compositions and uses thereof

LAUREN SCIENCES LLC2 citations65

B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV

1 patent
US12533417B2Jan 27, 2026

L-DOPA and/or DOPA decarboxylse inhibitors conjugated to sugar for the treatment of dopamine-responsive disorders

B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV0 citations56